In summary, these data suggest that Rapamycin affects the translation of mRNAs in a specific manner in pancreatic cancer cells that lack 4EBP1 expression likely through phospho-AKT and/or phospho-p90-RSK1 activation. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.